Roden D M
Vanderbilt University School of Medicine, Department of Medicine, Nashville, Tennessee 37232-6602, USA.
Clin Cardiol. 1997 Mar;20(3):285-90. doi: 10.1002/clc.4960200318.
The term torsade de pointes refers to polymorphic ventricular tachycardia that occurs in the setting of an abnormally long QT interval. While the most common cause is treatment with QT prolonging drugs, torsade de pointes also occurs in the congenital long QT syndromes and in the setting of acquired heart block or severe electrolyte disturbance, notably hypokalemia. Among QT prolonging drugs that cause torsade de pointes, both antiarrhythmics and "noncardioactive" drugs have been recognized. The electrocardiographic features of torsade de pointes include labile QT intervals, prominent U waves, and a "pause-dependent" onset of the arrhythmia. Treatment consists of recognition of the syndrome, correction of underlying electrolyte abnormalities, and withdrawal of any offending drugs. Magnesium, isoproterenol, or cardiac pacing provides specific antiarrhythmic therapy in torsade de pointes.
尖端扭转型室速这一术语指的是在QT间期异常延长情况下发生的多形性室性心动过速。虽然最常见的病因是使用可延长QT间期的药物,但尖端扭转型室速也见于先天性长QT综合征以及获得性心脏传导阻滞或严重电解质紊乱(尤其是低钾血症)的情况。在可导致尖端扭转型室速的延长QT间期药物中,抗心律失常药物和“非心脏活性”药物均已被确认。尖端扭转型室速的心电图特征包括QT间期不稳定、显著的U波以及心律失常呈“长间歇依赖性”发作。治疗包括识别该综合征、纠正潜在的电解质异常以及停用任何可疑药物。镁剂、异丙肾上腺素或心脏起搏可为尖端扭转型室速提供特异性抗心律失常治疗。